Study of the Metrological Properties of Two Assessment Grids of the Driving Capacity After a Cerebrovascular Accident (ROADTRIP) (ROADTRIP)
Study of the Metrological Properties of Two Assessment Grids of the Driving Capacity After a Cerebrovascular Accident :Recommendations of the HAS (Hight Autority of Health in France) and Test Ride for Investigation Practical Fitness to Drive
Precise recommendations concerning the methods of evaluation for the resumption of the driving after a not evolutionary stroke were recommended recently by the High Authority of Health. These describe among others elements to be estimated during the test on the road, in the presence of the driving instructor who remains Gold standard.
However, no standardized assessment grid serving as decision-making tool is at present validated.
Actually the test made by the unit of evaluation of the automobile resumption of the university hospital on the road, in a car of apprenticeship with double pedals and in the presence of a professional binomial (driving instructor and occupational therapist) then validated by the opinion of the doctor of the service. The current standard is thus very subjective and lack of sensibility.
It is necessary to study the metrological properties of both available assessment grids (that established from the recommendations of the HAS and TRIP), none of them reached a level of validation enough in this population.
The TRIP is this day validated only at the elderly people. The hypothesis of the search is an insufficiency of TRIP to estimate the patients presenting aftereffects of cerebrovascular accident.
The main objective of this work is to validate the new assessment grid after a study of its metrological properties in the situation of the driving on the road.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The patients will benefit a medical consultation to estimate the possibility of inclusion in the study. During this consultation, the results of the neuropsychological and ophthalmological examinations will be explored and a specificity of the sensitive-driving deficits presented by the patient will be estimated to recommend the arrangements of necessary vehicle if necessary.
All the inclusive patients will benefit then the first test of driving in "ecological" situation accompanied by a lasting driving instructor during 45minutes. The evaluation will be realized by a present occupational therapist and a neuropsychologist in the vehicle, on two different assessment grids.
The second test on road will be for the part of included patients and will be made with the driving instructor and the therapist.
Then, the third test on road will be realized after sessions on driving simulator for the part of the patients requiring a re-entrainment.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Clermont-Ferrand, Frankreich, 63000
- CHU clermont-ferrand
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- 18 Years to 80 Years
- Cognitive and/or sensitive-motor disorders after a cerebrovascular accident
- Candidate for resumption of driving on the road and having to pass an aptitude test
- French legal protection
Exclusion Criteria:
- Contraindications for resumption of driving on the road (visual field amputation, binocular visual acuity less than 5/10; cognitive impairment not compatible with driving; other medical contraindication).
- Protected populations not concerned by the study (guardianship, curatorship, deprived of the freedoms, safeguarding of justice).
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Diagnose
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Behavoiral
The evaluation will be realized on two different assessment grids during the test on the road
|
The data assessed during the road test from the two assessment grids (recommendations of the HAS and Test ride for investigation practical fitness to drive) : road position, vehicle control, track management, safety distances, speed, visual behavior, traffic signs, vehicle overtaking, anticipatory reactions and capabilities adaptation, attentional skills, decision-making, communication with other road users, assessment of specific situations such as insertion on a 2x2 lane, mechanical management and general impressions. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
The metrologic properties of the two evaluation grids (evaluation grids based on HAS and TRIP recommendations)
Zeitfenster: at day 1
|
Acceptability will be based on the calculation of missing data at the level of each item and for the overall score of the study grids.
Internal Consistency will be determined through Cronbach's alpha coefficient.
Internal validity will be determined by study of correlation between the domains composing of the HAS and TRIP grids.
Reproducibility .the
Kappa concordance correlation coefficient will be used to determine the test-retest reliability.
Internal validity will be determined by study of the correlation between of HAS and TRIP grids.
External validity will be based on the study of correlations of scores from HAS and TRIP grids (Pearson or Spearman according to statistical distribution).
|
at day 1
|
|
The metrologic properties of the two evaluation grids (evaluation grids based on HAS and TRIP recommendations)
Zeitfenster: at 1 month
|
Acceptability will be based on the calculation of missing data at the level of each item and for the overall score of the study grids.
Internal Consistency will be determined through Cronbach's alpha coefficient.
Internal validity will be determined by study of correlation between the domains composing of the HAS and TRIP grids.
Reproducibility .the
Kappa concordance correlation coefficient will be used to determine the test-retest reliability.
Internal validity will be determined by study of the correlation between of HAS and TRIP grids.
External validity will be based on the study of correlations of scores from HAS and TRIP grids (Pearson or Spearman according to statistical distribution).
|
at 1 month
|
|
The metrologic properties of the two evaluation grids (evaluation grids based on HAS and TRIP recommendations)
Zeitfenster: at 3 months
|
Acceptability will be based on the calculation of missing data at the level of each item and for the overall score of the study grids.
Internal Consistency will be determined through Cronbach's alpha coefficient.
Internal validity will be determined by study of correlation between the domains composing of the HAS and TRIP grids.
Reproducibility .the
Kappa concordance correlation coefficient will be used to determine the test-retest reliability.
Internal validity will be determined by study of the correlation between of HAS and TRIP grids.
External validity will be based on the study of correlations of scores from HAS and TRIP grids (Pearson or Spearman according to statistical distribution).
|
at 3 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
The sensitivity to change
Zeitfenster: at 3 months
|
The ability of the instrument to highlight a variation deemed relevant by experts, will be explored.
The analyses described above for the tests-retest comparisons analyses will be re-implemented, the calculation of the effect-size will be performed for each grid
|
at 3 months
|
|
The sensitivity to change
Zeitfenster: at day 1
|
The ability of the instrument to highlight a variation deemed relevant by experts, will be explored.
The analyses described above for the tests-retest comparisons analyses will be re-implemented, the calculation of the effect-size will be performed for each grid
|
at day 1
|
|
The sensitivity to change
Zeitfenster: at 1 month
|
The ability of the instrument to highlight a variation deemed relevant by experts, will be explored.
The analyses described above for the tests-retest comparisons analyses will be re-implemented, the calculation of the effect-size will be performed for each grid
|
at 1 month
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Sylvie Bardoux, University Hospital, Clermont-Ferrand
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- AOI 2016 BARDOUX
- 2017-A02276-47 (Andere Kennung: ANSM)
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .